Cipla
Search results
Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries. Subscribe on YouTube. Sun Pharma Story.
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe.
Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
Sun Pharma is the No. 1 and largest pharmaceutical company in India with over 8% market share in the domestic market (AIOCD AWACS for 12 months ending Sept 2023). The company has been ranked No. 1 with over 12 different classes of doctors (SMSRC Prescription Data).
1 day ago · Sun Pharma EPS has increased to Rs. 11.10 in March 2024 from Rs. 8.30 in March 2023. Sun Pharma shares closed at 1,516.25 on June 27, 2024 (NSE) and has given 22.92% returns over the last 6 months ...
3 days ago · Sun Pharmaceutical Industries Limited Stock Price Today, Live NSE Share Price: Get the latest Sun Pharmaceutical Industries Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active...
2 days ago · Get all the information on Sun Pharma with historic price charts for NSE / BSE. Experts & Broker view also get the Sun Pharma Ltd. buy/sell tips detailed news, announcements, Forecasts,...
Jun 21, 2024 · Show more companies. BENGALURU, June 21 (Reuters) - Japan's Takeda Pharmaceutical (4502.T) gave India's Sun Pharmaceutical (SUN.NS) and Cipla (CIPL.NS) the rights to commercialize gastrointestinal ...
Sun Pharmaceuticals Industries Limited, commonly known as Sun Pharma, on Monday, June 24, 2024, through a BSE exchange filing announced that the company had successfully completed the merger of ...
